NasdaqCM - Nasdaq Real Time Price USD

Cryoport, Inc. (CYRX)

8.53

+0.38

+(4.59%)

As of 3:07:39 PM EST. Market Open.

Cryoport Unveils State-of-the-Art Cryogenic Shipping System for Transporting Lifesaving Biologics and Temperature-Sensitive Therapies

Cryoport, Inc. (NASDAQ: CYRX) ("Cryoport" or "the Company"), a global leader in supply chain solutions for the life sciences, today unveiled its Cryoport Express® Cryogenic HV3 Shipping System ("HV3"), the Company's newest product innovation in Cryoport's comprehensive portfolio of global end-to-end temperature-controlled supply chain offerings.

PR Newswire yesterday

CYRX
+4.59%
Moffitt Cancer Center and Cryoport Announce Strategic Collaboration

Moffitt Cancer Center, a leading National Cancer Institute-designated comprehensive cancer center, through its wholly owned subsidiary Speros FL, a 775-acre global innovation life sciences campus, and Cryoport, Inc. (NASDAQ: CYRX), a global leader in supply chain solutions for the life sciences industry, today announced a strategic collaboration that will provide CRYOGENE's state-of-the-art biorepository services to Speros in Pasco County, Florida. Cryoport's CRYOGENE business unit is a leading

PR Newswire 8 days ago

CYRX
+4.59%
Cryoport's MVE Biological Solutions Registers All Manufacturing Facilities with the U.S. Food and Drug Administration ("FDA")

Cryoport, Inc. (NASDAQ: CYRX), a global leader in supply chain solutions for the life sciences industry, today announced that MVE Biological Solutions ("MVE"), a Cryoport company and the leading global manufacturer of high-quality cryogenic freezers and dewars, has officially registered all three of its manufacturing facilities (located in Ball Ground, Georgia; New Prague, Minnesota; and Chengdu, China) with the U.S. Food and Drug Administration ("FDA"). Additionally, all applicable MVE-manufact

PR Newswire 16 days ago

CYRX
+4.59%
Cryoport Expands IntegriCell™ Cryopreservation Services Solution with Opening of New Center of Excellence in Europe

Cryoport, Inc. (Nasdaq: CYRX) ("Cryoport" or the "Company"), a global leader in supply chain solutions for the life sciences industry, today announced the opening of its newest IntegriCell™ facility in Villers-le-Bouillet, Liege, Belgium. The Center of Excellence is now fully operational and prepared to support the development and commercialization of cell-based therapies with advanced cryopreservation solutions for leukapheresis, a common starting material.

PR Newswire 2 months ago

CYRX
+4.59%
Cryoport Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag

Cryoport ( NASDAQ:CYRX ) Third Quarter 2024 Results Key Financial Results Revenue: US$56.7m (flat on 3Q 2023). Net...

Simply Wall St. 2 months ago

CYRX
+4.59%
CryoPort Inc (CYRX) Q3 2024 Earnings Call Highlights: Strong Service Growth Amid Market Challenges

CryoPort Inc (CYRX) reports robust growth in life sciences services and maintains full-year revenue guidance despite sector-specific hurdles.

GuruFocus.com 2 months ago

CYRX
+4.59%
CryoPort, Inc. (CYRX) Reports Q3 Loss, Misses Revenue Estimates

CryoPort (CYRX) delivered earnings and revenue surprises of 92% and 2.52%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?

Zacks 2 months ago

CYRX
+4.59%
Cryoport Reports Third Quarter 2024 Financial Results

Cryoport, Inc. (NASDAQ: CYRX) (Cryoport), a global leader in supply chain solutions for the life sciences industry, today announced financial results for its third quarter (Q3) and first nine months (9M) of 2024.

PR Newswire 2 months ago

CYRX
+4.59%
CryoPort, Inc. (CYRX) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

CryoPort (CYRX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks 2 months ago

CYRX
+4.59%
SNDR
Cryoport to Report Third Quarter 2024 Financial Results on November 7, 2024

Cryoport, Inc. (Nasdaq: CYRX) ("Cryoport" or the "Company"), a global leader in supply chain solutions for the life sciences industry, today announced that the Company will report financial results for the third quarter ended September 30, 2024 on Thursday, November 7, 2024 after U.S. markets close.

PR Newswire 2 months ago

CYRX
+4.59%
Cryoport and Gulf Coast Regional Blood Center Launch Strategic Alliance to Enhance Cellular Therapy Services

Cryoport, Inc. (NASDAQ: CYRX) ("Cryoport"), a global leader in supply chain solutions for the life sciences industry, and Gulf Coast Regional Blood Center ("GCRBC"), a non-profit community blood center serving more than 26 counties throughout the state of Texas, today announced a strategic alliance to enhance the availability of high-quality, manufacture-ready cryopreserved allogeneic leukopaks for cellular therapy research, development, and treatment.

PR Newswire 2 months ago

CYRX
+4.59%
TMRW Life Sciences and Cryoport Systems Form Strategic Partnership to Elevate Standards for Frozen Egg, Embryo, and Sperm Offsite Storage and Biologistics

Cryoport, Inc. (NASDAQ: CYRX) ("Cryoport"), a global leader in supply chain solutions for the life sciences industry, and TMRW Life Sciences ("TMRW"), a fertility technology company offering the highest standard of care in offsite storage for frozen eggs, embryos and sperm in the U.S. with the only FDA-cleared automated specimen management and storage platform, today announced a strategic partnership to provide fertility clinics with complete solutions for secure specimen management and transpor

PR Newswire 3 months ago

CYRX
+4.59%
VGXI Selects Cryoport for Biostorage, Bioservices and Supply Chain Solutions to Advance Next-Generation Therapies

Cryoport, Inc. (NASDAQ: CYRX) ("Cryoport"), a global leader in supply chain solutions for the life sciences, and VGXI, Inc., (VXGI) a subsidiary of GeneOne Life Science Inc. ("GeneOne" KOSPI: 011000) today announced a strategic partnership to support biopharmaceutical companies in developing cell and gene therapies and mRNA-based treatments.

PR Newswire 3 months ago

CYRX
+4.59%
Cryoport Launches its IntegriCell™ Cryopreservation Solution with Opening of New Facility at its Houston Campus

Cryoport, Inc. (NASDAQ: CYRX) ("Cryoport" or "the Company"), a global leader in supply chain solutions for the life sciences, today announced the launch of its IntegriCell™ cryopreservation services solution provided by Cryoport Systems with the opening of its new facility located at Cryoport's integrated supply chain campus in Houston, Texas. This new state-of-the-art facility is dedicated to the standardized cryopreservation of leukapheresis material, seamlessly integrating this service with C

PR Newswire 3 months ago

CYRX
+4.59%
SK pharmteco and Cryoport Partner for Cell and Gene Therapy Logistics and BioServices

Cryoport, Inc. (NASDAQ: CYRX) ("Cryoport"), a global leader in supply chain solutions for the life sciences industry, and SK pharmteco, a global contract development and manufacturing organization, today announced a strategic collaboration to provide fully integrated logistics and manufacturing services to biotechnology and pharmaceutical companies.

PR Newswire 3 months ago

034730.KQ

034730.KS

03473K.KQ
Should You Hold Cryoport (CYRX)?

Brown Capital Management, an investment management company, released its “The Brown Capital Management Small Company Fund” second quarter 2024 investor letter. A copy of the letter can be downloaded here. The Small Company Fund returned -6.57%, underperforming the Russell 2000 Growth index’s 2.92% decline. Fundamental and macroeconomic factors drove the underperformance of the fund in […]

Insider Monkey 4 months ago

CYRX
+4.59%
Should You be Optimistic on the Growth Prospects of CryoPort (CYRX)?

Conestoga Capital Advisors, an asset management company, released its “Micro-Cap Strategy” second-quarter 2024 investor letter. A copy of the letter can be downloaded here. The second quarter of 2024 may be regarded as a time of moderation. Economic indicators largely reflected slowing growth and easing inflation. The moderation theme also drives equity markets. Large-cap stocks, as measured […]

Insider Monkey 5 months ago

CYRX
+4.59%
^RUT
CryoPort, Inc. (CYRX) Reports Q2 Loss, Lags Revenue Estimates

CryoPort (CYRX) delivered earnings and revenue surprises of 10.81% and 0.33%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?

Zacks 5 months ago

CYRX
+4.59%
Cryoport Reports Second Quarter 2024 Financial Results

Cryoport, Inc. (NASDAQ: CYRX) (Cryoport), a global leader in supply chain solutions for the life sciences, today announced financial results for its second quarter (Q2) and first half (H1) of 2024.

PR Newswire 5 months ago

CYRX
+4.59%
Cryoport Announces $200 Million Repurchase Program and the Repurchase of $160 Million of Convertible Senior Notes

Cryoport, Inc. (Nasdaq: CYRX) ("Cryoport" or the "Company"), a global leader in supply chain solutions for the life sciences, today announced that the Company's Board of Directors had authorized a repurchase program to purchase up to $200 million of the Company's common stock and/or convertible senior notes (the "2024 Repurchase Program"). The 2024 Repurchase Program became effective on August 1, 2024 and remains in effect through December 31, 2027.

PR Newswire 5 months ago

CYRX
+4.59%

Performance Overview

Return	CYRX	S&P 500
YTD	+8.73%	+3.19%
1-Year	-40.93%	+25.94%
3-Year	-79.57%	+38.59%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Cryoport, Inc. (CYRX)

Cryoport Unveils State-of-the-Art Cryogenic Shipping System for Transporting Lifesaving Biologics and Temperature-Sensitive Therapies

Moffitt Cancer Center and Cryoport Announce Strategic Collaboration

Cryoport's MVE Biological Solutions Registers All Manufacturing Facilities with the U.S. Food and Drug Administration ("FDA")

Cryoport Expands IntegriCell™ Cryopreservation Services Solution with Opening of New Center of Excellence in Europe

Cryoport Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag

CryoPort Inc (CYRX) Q3 2024 Earnings Call Highlights: Strong Service Growth Amid Market Challenges

CryoPort, Inc. (CYRX) Reports Q3 Loss, Misses Revenue Estimates

Cryoport Reports Third Quarter 2024 Financial Results

CryoPort, Inc. (CYRX) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

Cryoport to Report Third Quarter 2024 Financial Results on November 7, 2024

Cryoport and Gulf Coast Regional Blood Center Launch Strategic Alliance to Enhance Cellular Therapy Services

TMRW Life Sciences and Cryoport Systems Form Strategic Partnership to Elevate Standards for Frozen Egg, Embryo, and Sperm Offsite Storage and Biologistics

VGXI Selects Cryoport for Biostorage, Bioservices and Supply Chain Solutions to Advance Next-Generation Therapies

Cryoport Launches its IntegriCell™ Cryopreservation Solution with Opening of New Facility at its Houston Campus

SK pharmteco and Cryoport Partner for Cell and Gene Therapy Logistics and BioServices

Should You Hold Cryoport (CYRX)?

Should You be Optimistic on the Growth Prospects of CryoPort (CYRX)?

CryoPort, Inc. (CYRX) Reports Q2 Loss, Lags Revenue Estimates

Cryoport Reports Second Quarter 2024 Financial Results

Cryoport Announces $200 Million Repurchase Program and the Repurchase of $160 Million of Convertible Senior Notes

Performance Overview